Scott Kellen, CFO and Secretary at DiaMedica Therapeutics Inc. (DMAC), bought 1,250 shares at $4.00 ($5K) on 2018-12-11, disclosed to the SEC on 2018-12-11.
Open-market purchase of $5k DMAC by CFO and Secretary. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| DMAC | BUY | 2020-11-10 | $8K | — | Filing → |
| DMAC | BUY | 2019-08-19 | $7K | — | Filing → |
| DMAC | BUY | 2019-05-28 | $12K | — | Filing → |